FDA recall D-1052-2019

Rising Pharmaceuticals, Inc. · Class II · drug

Product

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30

Reason for recall

CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products

Distribution

Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.

Key facts

Status
Ongoing
Initiation date
2019-03-07
Report date
2019-03-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Saddle Brook, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1052-2019